Principal Securities, Inc. Pro Phase Labs, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 10,000 shares of PRPH stock, worth $5,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$5,300% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.68MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$341,7410.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$216,3810.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$137,3030.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$121,6100.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA218KShares$115,6070.01% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $8.49M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...